GLOW – GHK-Cu 50mg, BPC-157 10mg, TB-500 (TB4) 10mg (70mg Blend)

$84.99

  • GHK-Cu: 50mg
  • BPC-157: 10mg
  • TB-500 (TB4): 10mg
  • Total Listed Material: 70mg
  • Appearance: Blue to purplish-blue lyophilized powder
  • Vial Size: 5mL
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPGLO70 Categories: , Tags: , ,
Description

GLOW Peptide – GHK-Cu / BPC-157 / TB-500 Advanced Research Blend

GLOW peptide is a multi-component research blend containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 (TB4) 10mg. The three listed components provide a combined total of 70mg of research material in a 5mL vial.

The supplied material is described as a blue to purplish-blue lyophilized powder. Each component has its own sequence, molecular formula, molecular weight, PubChem identifier, and CAS number. Researchers should therefore evaluate the constituents individually when comparing this blend with molecular databases and scientific literature.

GLOW Peptide 70mg Research Blend

The GLOW peptide formulation combines three separately specified research materials:

Component Amount Molecular Weight CAS Number
GHK-Cu 50mg 340.384 g/mol 89030-95-5
BPC-157 10mg 1419.556 g/mol 137525-51-0
TB-500 (TB4) 10mg 4963 g/mol 77591-33-4

Because this is a multi-component research formulation, the complete blend should not be assigned one molecular formula, sequence, molecular weight, or PubChem identifier. Each constituent retains its own supplied molecular characteristics.

GHK-Cu 50mg in the GLOW Peptide Blend

GHK-Cu represents the largest listed component at 50mg.

The supplied sequence is:

Gly-His-Lys

Additional molecular specifications include:

  • Molecular Formula: C14H23CuN6O4
  • Molecular Weight: 340.384 g/mol
  • PubChem CID: 73587
  • CAS Number: 89030-95-5

Researchers can explore the supplied molecular formula through the PubChem GHK-Cu molecular formula search.

These identifiers provide useful reference points when documenting the material or comparing it with appropriately matched scientific resources.

BPC-157 10mg Research Component

BPC-157 is supplied at 10mg within the formulation.

The supplied sequence is:

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Additional specifications include:

  • Molecular Formula: C62H98N16O22
  • Molecular Weight: 1419.556 g/mol
  • PubChem CID: 9941957
  • CAS Number: 137525-51-0

The supplied formula can be explored through the PubChem BPC-157 molecular formula search.

Research involving this component should be distinguished from investigation of the complete three-component formulation.

TB-500 (TB4) 10mg Research Component

TB-500 (TB4) represents the third component of the GLOW peptide blend and is supplied at 10mg.

The provided sequence is:

Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH

Additional specifications include:

  • Molecular Formula: C212H350N56O78S
  • Molecular Weight: 4963 g/mol
  • PubChem CID: 16132341
  • CAS Number: 77591-33-4

Researchers can explore the supplied formula using the PubChem TB-500 molecular formula search.

These specifications can support molecular identification, laboratory documentation, and comparison with relevant scientific literature.

What Is GLOW Peptide?

The question what is GLOW peptide reflects informational search interest surrounding this blend.

Based strictly on the supplied product specifications, it is a 70mg multi-component research formulation containing:

  • 50mg GHK-Cu
  • 10mg BPC-157
  • 10mg TB-500 (TB4)

The material is supplied as a blue to purplish-blue lyophilized powder in a 5mL vial.

Because the formulation combines three separately characterized materials, researchers should distinguish information concerning an individual constituent from information specifically applicable to the complete blend.

GLOW Peptides and Multi-Component Research

The search variation glow peptides may be used when researchers are looking for information concerning this type of multi-component research formulation.

Scientific interpretation requires more than matching a product name. Each component should be identified using its sequence, molecular formula, molecular weight, PubChem identifier, and CAS number where applicable.

For the GLOW peptide, this is particularly important because the 70mg formulation contains three distinct materials rather than one compound.

Evidence involving GHK-Cu alone, for example, should not automatically be interpreted as evidence involving the complete GHK-Cu/BPC-157/TB4 combination.

GLOW Blend Peptide Benefits – Research Significance

The phrase glow blend peptide benefits reflects search interest in the potential significance of this formulation.

For research purposes, “benefits” should not be interpreted as established health, cosmetic, therapeutic, recovery, or performance outcomes.

Instead, researchers can evaluate the individual components and the complete blend through controlled experimental designs with predefined endpoints.

Relevant scientific questions may involve:

  • Molecular characterization
  • Analytical comparison
  • Cellular research models
  • Component-specific observations
  • Multi-component experimental models
  • Concentration-dependent observations
  • Comparative laboratory analysis

Any conclusions should remain limited to the experimental model, methodology, controls, and endpoints actually studied.

GLOW Peptide Molecular Documentation

Accurate documentation is particularly important when investigating a GLOW peptide formulation containing multiple research materials.

Laboratory records may include:

  • Product name
  • Identity of each component
  • Quantity of each component
  • Individual sequences
  • Molecular formulas
  • Molecular weights
  • PubChem identifiers
  • CAS numbers
  • Physical appearance
  • Vial size
  • Experimental concentration
  • Research model
  • Analytical methodology
  • Experimental endpoints

Recording these details can help researchers distinguish the complete blend from experiments involving only one of its constituents.

70mg Blend Composition

The three supplied component quantities total 70mg:

50mg + 10mg + 10mg = 70mg

This represents the total listed quantity of research material within the vial.

The 70mg total should not be interpreted as a recommended dose, injection quantity, treatment protocol, or personal-use amount.

Experimental concentrations must instead be established according to the research model, laboratory methodology, controls, and applicable experimental objectives.

Appearance and 5mL Vial Format

The supplied GLOW peptide material is described as a blue to purplish-blue lyophilized powder.

It is supplied in a 5mL vial.

These physical characteristics provide additional information for product identification and laboratory inventory documentation.

Researchers should record both physical and molecular specifications when maintaining experimental records, particularly when multiple formulations are being evaluated within the same research program.

Laboratory Research Considerations

Controlled investigation involving the GLOW peptide blend should use clearly defined methodology and appropriate experimental controls.

Relevant considerations may include:

  • Identity of each constituent
  • Experimental concentration
  • Research model selection
  • Appropriate controls
  • Sample preparation
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Potential multi-component interactions
  • Reproducibility
  • Data interpretation

Researchers should distinguish evidence concerning individual components from evidence concerning combinations.

Similarly, findings generated in in-vitro, animal, or human studies represent different evidence settings and should not automatically be treated as interchangeable.

Related OROS Research Materials

Researchers exploring additional laboratory materials can review Thymosin Alpha-1 5mg as a separately specified research product.

Another catalog option is Vesugen 20mg, which should be evaluated according to its own supplied characteristics.

Researchers can also explore Vilon 20mg as another independently specified material in the OROS Research catalog.

These products should not be interpreted as chemically, structurally, or experimentally interchangeable with this blend.

Scientific Research Resources

Researchers can use PubChem to investigate available molecular records, compound identifiers, and chemical database information for individual components.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

When reviewing scientific publications, researchers should verify which exact compound or combination was investigated and consider the experimental model, methodology, controls, endpoints, and study limitations.

GLOW Peptide Research FAQ

What is GLOW peptide?

The supplied formulation is a multi-component research blend containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 (TB4) 10mg.

How much total material does the blend contain?

The three listed components provide a combined total of 70mg.

What does the material look like?

It is described as a blue to purplish-blue lyophilized powder.

What vial size is supplied?

The research blend is supplied in a 5mL vial.

Does the blend contain GHK-Cu?

Yes. GHK-Cu is the largest listed component at 50mg.

Does the blend contain BPC-157 and TB-500?

Yes. The supplied formulation contains 10mg BPC-157 and 10mg TB-500 (TB4).

What are GLOW blend peptide benefits?

The supplied product information does not establish health or therapeutic benefits. Research significance should be evaluated through appropriately controlled experiments and relevant scientific literature.

Does 70mg represent a recommended dose?

No. The 70mg figure represents the combined quantity of the three listed research materials. It is not a recommended human dose or administration amount.

Research Use Disclaimer

This GLOW peptide multi-component material is supplied exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. It is not intended for human or animal consumption, injection, therapeutic application, diagnosis, clinical use, self-administration, cosmetic treatment, bodybuilding, performance enhancement, or veterinary application. Experimental work should be performed by qualified personnel using appropriately validated laboratory procedures.

Additional information
Net Weight

70mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “GLOW – GHK-Cu 50mg, BPC-157 10mg, TB-500 (TB4) 10mg (70mg Blend)”

Your email address will not be published. Required fields are marked *